The Cancer Immunoprevention Network (CIP-Net) is offering this grant to advance the field of cancer immunoprevention. The primary goal is to deepen the understanding of basic immunoprevention mechanisms, identify novel strategies, and cultivate a collaborative community among researchers. Projects funded through the UG3/UH3 phases will facilitate de novo discovery of immune pathways and immunoprevention mechanisms. Additionally, research will investigate new vaccine targets and immunomodulatory agents. Applicants must submit a combined UG3/UH3 proposal, with successful achievement of UG3 milestones being essential for progression to the UH3 phase, ensuring continued support for impactful research in this vital area.
Opportunity ID: 347651
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-23-029 |
| Funding Opportunity Title: | Cancer Immunoprevention Network (CIP-Net) ?Research Projects (UG3/UH3 Clinical Trials Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 20, 2023 |
| Last Updated Date: | Apr 20, 2023 |
| Original Closing Date for Applications: | Jul 03, 2024 |
| Current Closing Date for Applications: | Jul 03, 2024 |
| Archive Date: | Aug 08, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Independent school districts Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities County governments Special district governments Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) For profit organizations other than small businesses Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments State governments Public and State controlled institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of the Cancer Immunoprevention Network (CIP-Net) is to support a deeper understanding of basic mechanisms of immunoprevention, discover novel immunoprevention strategies, and foster a community of cancer immunoprevention researchers. ?The UG3/UH3 research projects will enable de novo discovery of immune pathways, immunoprevention mechanisms, or investigation of new vaccine or immunomodulatory targets or agents. Applicants responding to this FOA must apply for both the UG3 and UH3 phases together in a single application. Achievement of the UG3 milestones will be necessary for transition to the UH3 phase. UH3 phase may be awarded after administrative review of the UG3 milestones. Provided these milestones are achieved, UH3 phase may continue. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-23-029.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 347651 Full Announcement-RFA-CA-23-029 -> RFA-CA-23-029-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00281272 | Jun 03, 2023 | Jul 03, 2024 | View |
Package 1
Mandatory forms
347651 RR_SF424_5_0-5.0.pdf
347651 PHS398_CoverPageSupplement_5_0-5.0.pdf
347651 RR_OtherProjectInfo_1_4-1.4.pdf
347651 PerformanceSite_4_0-4.0.pdf
347651 RR_KeyPersonExpanded_4_0-4.0.pdf
347651 RR_Budget_3_0-3.0.pdf
347651 PHS398_ResearchPlan_5_0-5.0.pdf
347651 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
347651 RR_SubawardBudget30_3_0-3.0.pdf
347651 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
